nangibotide inhibitor receptor found certain white blood cells activation stimulates inflammation nangibotide therefore investigated treatment overwhelming inflammation typically seen severe sepsis nangibotide polypeptide derived receptor found neutrophils macrophages monocytes key elements immune system activation results expression nfÎºb promotes systemic inflammation nangibotide inhibits thereby preventing inflammatory activation absence results vastly reduced inflammation without impairing ability fight mouse equivalent nangibotide improves survival mouse models severe pig model sepsis another animal equivalent nangibotide resulted significantly improved haemodynamics less organ monkeys also reduced inflammatory hypotensive effects nangibotide demonstrated safety phase healthy phase sick patients septic studies astonish trial examine clinical efficacy patients septic httpsenwikipediaorgwikinangibotide